Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Neurology | Oncology
Clinical Trials: Brain Metastases
A listing of clinical trials currently looking for volunteers to enroll in Brain Metastases studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : University of Alabama At Birmingham
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
California
La Jolla : Univ. of California at San Diego Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Los Angeles : University of Southern California Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
San Francisco : University of California At San Francisco
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Florida
Coral Springs : Northwest Hematology and Oncology Associates Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Tampa : Moffitt Cancer Center Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Tampa : H. Lee Moffitt Cancer Center & Research Institute
Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors
Georgia
Athens : Northeast Georgia Cancer, LLC Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Illinois
Chicago : University of Chicago
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Harvey : Ingalls Memorial Hospital Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Indiana
Indianapolis : Indiana University Simon Cancer Center
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Indianapolis : Indiana University Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Kansas
Witchita : Cancer Center of Kansas Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Maryland
Baltimore : Johns Hopkins University
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Massachusetts
Boston : Dana Farber Cancer Institute
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Boston : Beth Israel Deaconess Medical Center
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Boston : Dana-Farber Cancer Institute
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Boston : Dana Farber Cancer Institute Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Michigan
Ann Arbor : University of Michigan
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Detroit : Henry Ford Hospital Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
New York
New York city : Department of Radiation oncology, Memorial Sloan Kettering Cancer Center
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
North Carolina
Chapel Hill : University of North Carolina-CH Lineberger Comprehensive Cancer Center
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Chapel Hill : Univ. of North Carolina Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Durham : Duke University
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Ohio
Cleveland : University Hospitals Seidman Cancer Center Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Pennsylvania
Philadelphia : Thomas Jefferson University
Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases
Pittsburgh : University of Pittsburgh Medical Center
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Pittsburgh : UPMC Shadyside Radiation Oncology
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Tennessee
Memphis : The West Clinic Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Nashville : Vanderbilt University
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Nashville : Tennessee Oncology Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Texas
Houston : MD Anderson Cancer Center
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Austria
Graz : Graz Medical University
Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.
Belgium
Antwerp : Universitair Ziekenhuis Antwerpen
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Brussels : Jules Bordet Institute
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Canada
Toronto : Sunnybrook Updated
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
China
Chengdu : West China Hospital
Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation
Lianyungang : The First People's Hospital of Lianyungang
Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases
Israel
Petach Tikva : Rabin Medical Center
Evaluation of [18F]-ML-10 as a PET Imaging Radiotracer for Early Detection of Response of Brain Metastases to Whole Brain Radiation Therapy
Netherlands
Amsterdam : Vrije Universiteit medisch centrum (Vumc)
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Amsterdam : Antoni van Leeuwenhoek Ziekenhuis
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Leiden : Leids Universitair Medisch Centrum (LUMC)
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Rotterdam : Erasmus MC
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
United States
Washington : Georgetown University
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
